#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunoglobulin G4 related disease Plasma cell myeloma Neuroendocrine tumour of the lung Round cell liposarcoma Cystic fibrosis Partial lipodystrophy Meningococcal immunisation Chronic graft versus host disease in liver Blood iron increased Precursor T-lymphoblastic lymphoma/leukaemia recurrent Fms-like tyrosine kinase 3 positive Acute graft versus host disease in liver Angiosarcoma recurrent Depression Cystic fibrosis lung More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Sarcoidosis – Treatment Haemophagocytic lymphohistiocytosis – Trials in Disease Primary immunodeficiency syndrome – Treatment X-linked lymphoproliferative syndrome Pleural mesothelioma malignant – Life with Disease Hyperoxaluria Haemolytic uraemic syndrome Undifferentiated sarcoma – Treatment Thrombotic thrombocytopenic purpura – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Silibinin POLYMYXIN B SULFATE ADMILPARANT Pantothenate Sodium Bi 3720931 Carvedilol Xenon (129Xe) Abiraterone Acetate Emavusertib Dexrazoxane Rbl015.2 Cln-081 Clazakizumab Cangrelor Tetrasodium Rosuvastatin Colistimethate Sodium Duloxetine Gad20-209-Fsp-A1 Loperamide Hydrochloride Bgb-15025 Citrate More therapies…

    Learn about Your Condition

    Pseudomyxoma peritonei Mesothelioma Pneumonia chlamydial Periarthritis Streptococcal infection Pleomorphic liposarcoma Colorectal cancer stage III Angiosarcoma Femoral hernia Laparoscopic surgery Polyneuropathy ROHHAD syndrome Incisional hernia Renal cancer recurrent Partial seizures More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diagnosis

  • Study on the Effects of the Dengue Vaccine Qdenga on Antibody Levels in Swedish Travelers

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dengue fever
    Sweden

  • Study on Heart Failure Patients Using Hyperpolarized [1-13C]pyruvate to Explore Heart Metabolism

    Recruiting

    1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on the Effects of Different Doses of Adenosine for Patients with Chronic Coronary Syndrome, with and without Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • Gadoteric Acid
    • Adenosine
    Sweden

  • Study on [18F]-AlF-FAPI-74 for Staging Advanced Stomach Cancer in Patients Using PET/CT and Laparoscopy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    The Netherlands

  • Study on Fluorouracil and Drug Combination for Patients with Metastatic Colorectal Cancer to Evaluate Drug Sensitivity

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Fluorouracil
    Norway

  • Study on Water Absorption in the Brain for Adults with Hydrocephalus Using O15-Water

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hydrocephalus
    Investigated Drugs:
    • O15-Water
    Norway
Previous Page
1 2 3 4 5 … 22
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!